Physician profile
David B Parrett
NPI 1588640031
$1,387.38
in general payments reported to CMS, 2019-2025
19 companies · $21.61 in 2025
The $21.61 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $145 · 2022: $15.67 · 2023: $15.90 · 2024: $31.80 · 2025: $21.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $248.28 | 2019-2020 | |
| Allergan, INC. | $139.44 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $128.19 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $118.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.54 | 2019-2020 | |
| Tosoh Bioscience, INC. | $95.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.38 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $64.36 | 2019 | |
| Amgen INC. | $63.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.81 | 2019 | |
| Supernus Pharmaceuticals, INC. | $48.25 | 2019 | |
| Novo Nordisk INC | $44.97 | 2019 | |
| Daiichi Sankyo INC. | $31.87 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.20 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $29.43 | 2019 | |
| Abbott Laboratories | $15.67 | 2022 | |
| Glaxosmithkline, LLC. | $13.37 | 2019 | |
| Astellas Pharma US INC | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.